Krystexxa
RxNorm concept 1011654, brand name (bn).
- RxCUI
- 1011654
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1011654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- pegloticase 8 MG/ML [Krystexxa] (SBDC, ingredient of)
- 1 ML pegloticase 8 MG/ML Injection [Krystexxa] (SBD, ingredient of)
- Krystexxa Injectable Product (SBDG, ingredient of)
- pegloticase Injection [Krystexxa] (SBDF, ingredient of)
- pegloticase 0.16 MG/ML [Krystexxa] (SBDC, ingredient of)
- 50 ML pegloticase 0.16 MG/ML Injection [Krystexxa] (SBD, ingredient of)
- pegloticase (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1011654 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1011654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1011654. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.